Vivos Therapeutics
Price & Volume
Stats
See more52W Range | $1.98-$7.95 |
Market Cap | $23.4M |
Shares Short | 260,244 |
Financials
See moreRevenue (12 Mos) | $14.3M |
Revenue Growth (YoY) | -5.8% |
Gross Profit (12 Mos) | $8M |
Diluted EPS | -$1.16 |
News
See moreYahoo Finance • 2 days ago
Vivos Therapeutics Releases Additional Clinical Data Showing Marked Improvement in Pediatric ADHD from Use of Vivos DNA Device
Yahoo Finance • 8 days ago
SJM Makes Bullish Cross Above Critical Moving Average
Yahoo Finance • 15 days ago
Vivos Therapeutics Announces Landmark Clinical Trial Results in Pediatric Obstructive Sleep Apnea Treatment
Yahoo Finance • last month
Vivos Therapeutics Reports Second Quarter 2025 Financial Results and Provides Operational Update
About
CEO | Mr. R. Kirk Huntsman |
CFO | Mr. Bradford K. Amman |
Address | 7921 Southpark Plaza, Littleton, CO, United States, 80120 |
Sector | Healthcare |
Industry | Medical Devices |
Full-Time Employees | 113 |
